miR-24 promotes glioma development by acting on the caudal-type homeobox 1 (CDX1) target to activate the PI3K/Akt signaling pathway, promote cell proliferation, and induce apoptosis (Lei et al., 2021). This evidence concerns the gene CDX1 and central nervous system cancer.